EU efforts to assess Russia’s Sputnik V vaccine stymied by data gaps

The developers of Russia’s Sputnik V coronavirus vaccine have repeatedly failed to provide data that regulators deem to be standard requirements of the drug approval process, according to five people with knowledge of EU efforts to assess the drug.